Dublin, May 18, 2022 (GLOBE NEWSWIRE) -- The "LAMEA Insulin Syringes Market Size, By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Country and Growth Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering. The Latin America, Middle East and Africa Insulin Syringes Market is expected to witness market growth of 8.1% CAGR during the forecast period (2021-2027). The insulin dosage determines the appropriate syringe size for individuals. One may need various syringe sizes to modify your insulin dose as needed because the insulin dose may alter based on the blood sugar levels. Insulin needles are available in a variety of diameters and thicknesses. The length of a needle controls how far it can penetrate your skin. Insulin needles should only penetrate just beneath the skin, not into muscle. Shorter needles are less likely to penetrate the muscle. Insulin is administered subcutaneously, or beneath the skin, into the fat layer. A short needle is utilized to inject insulin into the fatty layer between the muscle andskin in this sort of injection. Obesity rates among children and adolescents in Gulf countries range from 5% to 14% for men and 3% to 18% for girls. Obesity is on the rise in the Gulf area, with prevalence rates ranging from 2 percent to 55 percent in adult females and 1 percent to 30 percent in adult males. Obesity in the UAE is twice as high as the worldwide norm; in Kuwait, more than half of the adult population has diabetes connected to obesity, and 75 percent of Egyptians are overweight; medical experts blame the desert environment. The Brazil market dominated the LAMEA Insulin Syringes Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $44.5 million by 2027. The Argentina market is expected to exhibit a CAGR of 8.6% during (2021 - 2027). Additionally, The UAE market is poised to grow a CAGR of 7.8% during (2021 - 2027). Based on Disease, the market is segmented into Type 2 Diabetes and Type 1 Diabetes. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1CC Syringe (1ml) and Others. Based on End User, the market is segmented into Hospitals & Clinics, Homecare Settings, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hindustan Syringes & Medical Devices Ltd., Novo Nordisk A/S, Biocon Limited, Eli Lilly and Company, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health, Inc., Medline Industries, Inc., Terumo Corporation, and Nipro Corporation.
Key Topics Covered: Chapter 1. Market Scope & Methodology Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.1.1 Market Composition and Scenario 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints Chapter 3. LAMEA Insulin Syringes Market by Disease 3.1 LAMEA Type 2 Diabetes Market by Country 3.2 LAMEA Type 1 Diabetes Market by Country Chapter 4. LAMEA Insulin Syringes Market by Syringe Size 4.1 LAMEA 3/10 CC Syringe (0.3ml) Market by Country 4.2 LAMEA 1/2 CC Syringe (0.5ml) Market by Country 4.3 LAMEA 1CC Syringe (1ml) Market by Country 4.4 LAMEA Other Syringe Size Market by Country Chapter 5. LAMEA Insulin Syringes Market by End User 5.1 LAMEA Hospitals & Clinics Market by Country 5.2 LAMEA Homecare Settings Market by Country 5.3 LAMEA Others Market by Country Chapter 6. LAMEA Insulin Syringes Market by Country 6.1 Brazil Insulin Syringes Market 6.1.1 Brazil Insulin Syringes Market by Disease 6.1.2 Brazil Insulin Syringes Market by Syringe Size 6.1.3 Brazil Insulin Syringes Market by End User 6.2 Argentina Insulin Syringes Market 6.2.1 Argentina Insulin Syringes Market by Disease 6.2.2 Argentina Insulin Syringes Market by Syringe Size 6.2.3 Argentina Insulin Syringes Market by End User 6.3 UAE Insulin Syringes Market 6.3.1 UAE Insulin Syringes Market by Disease 6.3.2 UAE Insulin Syringes Market by Syringe Size 6.3.3 UAE Insulin Syringes Market by End User 6.4 Saudi Arabia Insulin Syringes Market 6.4.1 Saudi Arabia Insulin Syringes Market by Disease 6.4.2 Saudi Arabia Insulin Syringes Market by Syringe Size 6.4.3 Saudi Arabia Insulin Syringes Market by End User 6.5 South Africa Insulin Syringes Market 6.5.1 South Africa Insulin Syringes Market by Disease 6.5.2 South Africa Insulin Syringes Market by Syringe Size 6.5.3 South Africa Insulin Syringes Market by End User 6.6 Nigeria Insulin Syringes Market 6.6.1 Nigeria Insulin Syringes Market by Disease 6.6.2 Nigeria Insulin Syringes Market by Syringe Size 6.6.3 Nigeria Insulin Syringes Market by End User 6.7 Rest of LAMEA Insulin Syringes Market 6.7.1 Rest of LAMEA Insulin Syringes Market by Disease 6.7.2 Rest of LAMEA Insulin Syringes Market by Syringe Size 6.7.3 Rest of LAMEA Insulin Syringes Market by End User Chapter 7. Company Profiles 7.1 Hindustan Syringes & Medical Devices Ltd. 7.1.1 Company Overview 7.2 Novo Nordisk A/S 7.2.1 Company Overview 7.2.2 Financial Analysis 7.2.3 Segmental & Regional Analysis 7.2.4 Research & Development Expenses 7.2.1 Recent strategies and developments: 7.2.1.1 Acquisitions and Mergers: 7.3 Biocon Limited 7.3.1 Company Overview 7.3.2 Recent strategies and developments: 7.4 Eli Lilly and Company 7.4.1 Company Overview 7.4.2 Financial Analysis 7.4.3 Regional Analysis 7.4.4 Research & Development Expense 7.4.5 Recent Strategies and Developments: 7.4.5.1 Partnerships, Collaborations, and Agreements: 7.4.5.2 Product Launches and Product Expansions: 7.4.5.3 Approvals and Trials: 7.5 Abbott Laboratories 7.5.1 Company Overview 7.5.2 Financial Analysis 7.5.3 Segmental and Regional Analysis 7.5.4 Research & Development Expense 7.5.5 Recent strategies and developments: 7.5.5.1 Partnerships, Collaborations, and Agreements: 7.6 Becton, Dickinson and Company 7.6.1 Company Overview 7.6.2 Financial Analysis 7.6.3 Segmental and Regional Analysis 7.6.4 Research & Development Expense 7.6.5 Recent strategies and developments: 7.6.5.1 Approvals and Trials: 7.9 Terumo Corporation 7.9.1 Company Overview 7.9.2 Financial Analysis 7.9.3 Segmental Analysis 7.10. Nipro Corporation 7.10.1 Company Overview 7.10.2 Financial Analysis 7.10.3 Segmental and Regional Analysis 7.10.4 Research & Development Expenses For more information about this report visit https://www.researchandmarkets.com/r/o3imf8
Celebrations may be in order for ZIM Integrated Shipping Services Ltd. ( NYSE:ZIM ) shareholders, with the analysts...
One analyst says investors should focus on the chip equipment maker's outlook for forward demand.
Despite a disappointing quarter, sales remain strong, and the big retailer eventually will overcome inflation and supply-chain problems Also, Wall Street opinions on JD.com, Palo Alto Networks, Analog Devices, and Tupperware.
The first-quarter results for IZEA Worldwide, Inc. ( NASDAQ:IZEA ) were released last week, making it a good time to...
Janus International Group, Inc. ( NYSE:JBI ) defied analyst predictions to release its first-quarter results, which...
Bond yields have soared this year and are poised to rise further as the Fed prepares to lift rates multiple times.
Shares of Chinese electric-vehicle maker NIO closed higher Friday in their first trading day in Singapore, the third exchange on which investors can trade the stock. NIO (ticker: NIO) stock began trading at $16.90 and rose to as high as $20.29 on the Singapore exchange. U.S.-listed shares of NIO closed Thursday on the New York Stock Exchange at $16.66.
We’re likely to continue to see further downside pressure with the bears eyeing the March 4, 2021 bottom at 29987 as their next target.
Russia will cut off natural gas to Finland after the Nordic country that applied for NATO membership this week refused President Vladimir Putin's demand to pay in rubles, the Finnish state-owned energy company said Friday, the latest escalation over European energy amid the war in Ukraine.
The buys were made via venture capital firm Paradigm, of which Ehrsam is a co-founder and managing partner.
Big drops could be good news if they mean that investors are bringing the market to a bottom. How to not get mauled.
BRISBANE (Reuters) -Woodside Petroleum's shareholders on Thursday voted for a merger with BHP Group's petroleum arm to create a top 10 global independent oil and gas producer worth $40 billion, according to a vote count at the company's annual meeting. The merger, agreed last August, advances top global miner BHP's effort to move away from fossil fuels, as it looks to decarbonise, while doubling Woodside's oil and gas production and beefing up its funding for growth. "The merger is an opportunity for Woodside to increase its contribution to the world's growing energy needs and build the scale, resilience and diversity to thrive through the energy transition," Chief Executive Officer Meg O'Neill told shareholders.
(Reuters) -European shares slumped 1.5% on Thursday, stretching declines to the second straight session, as dismal results from big U.S. retailers underlined the hit from surging inflation on the world's biggest economy. Tracking U.S. peers, European retailers fell nearly 2% and were the biggest drags on the pan-European STOXX 600 index, which extended declines after a 1% slide on Wednesday. U.S. stock futures pointed to a fresh sell-off after Target Corp's quarterly profit halved and Walmart cut its profit view as they struggle with rising fuel and freight costs, while consumers shift their spending away from big-ticket purchases to essentials.
(Bloomberg) -- Inside JPMorgan Chase & Co., senior executives are counting on an investor day to redeem themselves from a routine January conference call now widely viewed as disastrous.Most Read from BloombergOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightElon Musk Gets Defensive Over Twitter Meme as Harassment Report SurfacesStocks Avert Bear Market, Slide for Seventh Week: Markets WrapApple Shows AR/VR Headset to Board in Sign of Progress on Key Project
A new research partnership aims to clarify best practices and help industry come to grips with disclosing Scope 3 GHG emissions.
The maker of semiconductor equipment reported sales and earnings below analyst estimates, sending shares lower after hours.
Americans may be afraid to look at their retirement accounts thanks to stock market volatility, but many investors are still staying the course, according to Fidelity Investments’ most recent data released Thursday. The savings rate for 401(k) plans reached a record level of 14%, just one percentage point away from the recommended 15% Fidelity suggests to retirement savers, according to Fidelity’s 2022 first-quarter data of its participants. “We have more and more retirement savers not making changes based on short-term market events,” said Mike Shamrell, a Fidelity Investments spokesman.
Schroders, Britain's biggest listed asset manager, said on Wednesday it would back a swathe of shareholder resolutions at Amazon, Meta and Google-owner Alphabet concerning workers' and digital rights. Schroders, which manages around 730 billion pounds ($905.64 billion), said it was declaring its intention to vote against management on the issues as an escalation measure following talks with the companies. In total, Schroders said it would vote against 11 resolutions across the three companies at their annual general meetings.
Elon Musk has made a name for himself and Tesla by breaking the rules, but the billionaire's latest comments on politics and a claim of sexual harassment against him that he said is untrue may hurt the brand in the eyes of some car owners and employees. The previous day, the Tesla chief executive, in the midst of a contentious effort to buy Twitter Inc, said he would now vote Republican instead of Democrat and called the Democrats a "party of division and hate." Tesla also was cut this week from the widely followed S&P 500 ESG Index, which an index executive said was due to issues including claims of racial discrimination within the company and crashes linked to its vehicles.
Colorado Economic Development Commission members also approved incentives for a software company considering opening its U.S. tech hub in Denver.